Intage Holdings Inc. logo

Intage Holdings Inc. (4326)

Market Closed
10 Aug, 06:00
JPX JPX
¥
1,861. 00
-30
-1.5865%
¥
65.91B Market Cap
- P/E Ratio
96% Div Yield
28,700 Volume
- Eps
¥ 1,891
Previous Close
Add Transaction
Day Range
1,861 1,891
Year Range
1,598 2,095
Want to track 4326 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4326 closed yesterday lower at ¥1,861, a decrease of -1.5865% from Friday's close, completing a monthly increase of 8.0093% or ¥138. Over the past 12 months, 4326 stock gained 4.7271%.
4326 pays dividends to its shareholders, with the most recent payment made on Jun 29, 2026. The next estimated payment will be in In 4 months on Dec 29, 2026 for a total of ¥24.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Intage Holdings Inc. has completed 2 stock splits, with the recent split occurring on Sep 27, 2017.
The company's stock is traded on one exchange.

4326 Chart

People also search for

Daiichikosho Co., Ltd.
¥ 1,816
-1.3043%
DTS Corporation
¥ 1,050
+0.1908%
Shochiku Co., Ltd.
¥ 10,650
-2.2039%
Anycolor Inc.
¥ 2,772
+1.5757%
Tsuburaya Fields Holdings Inc.
¥ 2,478
-1.1962%

Intage Holdings Inc. (4326) FAQ

What is the stock price today?

The current price is ¥1,861.00.

On which exchange is it traded?

Intage Holdings Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4326.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 96%.

What is its market cap?

As of today, the market cap is 65.91B.

Has Intage Holdings Inc. ever had a stock split?

Intage Holdings Inc. had 2 splits and the recent split was on Sep 27, 2017.

Intage Holdings Inc. Profile

Media Industry
Communication Services Sector
Mr. Yoshiya Nishi CEO
JPX Exchange
JP3152790006 ISIN
Japan Country
3,309 Employees
29 Jun 2026 Last Dividend
27 Sep 2017 Last Split
- IPO Date

Overview

INTAGE HOLDINGS Inc., headquartered in Tokyo, Japan, is a prominent entity in the field of marketing research with a global outreach. Founded in 1960, the company initially operated under the name INTAGE Inc. before it rebranded to INTAGE HOLDINGS Inc. in October 2013. The company offers its extensive services across various industries including consumer goods, healthcare, IT, and government agencies, among others. It has established its reputation by offering in-depth market insights and analytics to aid businesses in strategic planning and execution. As of October 16, 2023, it stands as a subsidiary of the influential NTT DOCOMO, INC., marking a significant phase in its operational and strategic evolution.

Products and Services

Marketing Support (Consumer Goods & Services)

This segment focuses on providing comprehensive research services that aid consumer goods manufacturers, advertisers, durable goods companies, and IT sectors. Services range from panel and custom research to in-depth market analysis, ensuring clients have the necessary data for informed decision-making.

Marketing Support (Healthcare)

INTAGE HOLDINGS Inc. excels in delivering precise marketing support tailored for the healthcare industry. This includes promotion services, prescription information analysis, and extensive marketing surveys for both over-the-counter (OTC) and prescription drugs. Pharmaceutical companies benefit greatly from these services, as they offer actionable insights for product marketing and positioning.

Business Intelligence

The company offers cutting-edge solutions in system development/operation, business process outsourcing (BPO), and data center operations. This is further augmented with services in system construction, data evaluation, analysis, and consultation, employing advanced techniques such as artificial intelligence (AI). These services cater to a broad spectrum of industries, including pharmaceutical, manufacturing, travel, publishing, and consumer goods, by providing valuable insights and operational efficiency enhancements.

Contract Research Organization (CRO)

As a CRO, INTAGE HOLDINGS Inc. takes a significant role in the pharmaceutical industry by handling research responsibilities on behalf of other companies. This includes a variety of services from the development of pharmaceuticals to the execution and management of clinical trials, ensuing that products meet the stringent requirements for market entry.

Contact Information

Address: INTAGE Akihabara Building
Phone: 81 3 5294 7411